MLPH Financials 07/16/2014 15:08:27 Molecular Pha

MLPH Financials 07/16/2014 15:08:27
Molecular Pharmacology (USA), Ltd.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 209 179 121 116
Non-Recurring Items - - - -
Other - - 1 1
Operating Income (209) (179) (122) (117)
Income From Continuing Operations
Add'l Income/Expense Items (1) - - -
Earnings Before Interest and Tax (210) (179) (122) (117)
Interest Expense - - - -
Earnings Before Tax (210) (179) (122) (117)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (210) (179) (122) (117)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (210) (179) (122) (117)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (210) (179) (122) (117)